Osiris Therapeutics (Osiris Therapeutics) Growth Rank : 0 (As of May. 05, 2024)

View and export this data going back to 2006. Start your Free Trial

What is Osiris Therapeutics Growth Rank?

Osiris Therapeutics has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Osiris Therapeutics Growth Rank Related Terms

Thank you for viewing the detailed overview of Osiris Therapeutics's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Osiris Therapeutics (Osiris Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Osiris Therapeutics Inc (NAS:OSIR) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

7015 Albert Einstein Drive, Columbia, MD, USA, 21046-1707

Website

http://www.osiris.com

Osiris Therapeutics is a biotechnology company involved in researching, developing, and marketing cellular regenerative medicine products. The company's therapeutic areas focus on innovation in regenerative medicine, including bioengineering, stem cell research, and viable tissue-based products. Osiris has accomplished commercial success with products in orthopedics, sports medicine, and wound care, such as Cartiform, Ovation, and Grafix.

Executives

Reinhart Charles A. Iii	director	C/O PACIRA PHARMACEUTICALS, INC., 5 SYLVAN WAY, SUITE 300, PARSIPPANY NJ 07054
Linda L Chang	officer: Chief Financial Officer	ONE PARK PLACE, STE 450, ANNAPOLIS MD 21401
Shauna L Vernal	officer: Chiel Legal Officer
Linda Palczuk	officer: President & CEO	7015 ALBERT EINSTEIN DRIVE, COLUMBIA MD 21046
David L White	director
Thomas J Knapp	director	4640 SW MACADAM AVE., SUITE 270, PORTLAND OR 97239
Jonathan Mark Hopper	officer: Chief Medical Officer	64 SIDNEY STREET, CAMBRIDGE MA 02139
Jacoby Philip R Jr	officer: Principal Accounting Officer
C Randal Mills	director, officer: President & CEO	18366 CALLE STELLINA, RANCHO SANTA FE CA 92091
Jay M Moyes	director
Stephen W Potter	officer: Senior Vice President	7015 ALBERT EINSTEIN DR, COLUMBIA MD 21046
Gregory Hurd Barnhill	director